Medpace Holdings (MEDP) Cash from Investing Activities (2015 - 2026)

Medpace Holdings has reported Cash from Investing Activities for 12 years, with the latest figure at -$6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 32.43% year-over-year to -$6.7 million; the trailing twelve-month figure through Mar 2026 stood at -$27.9 million (up 31.66% YoY), and the FY2025 full-year result was -$31.1 million, down 10.0% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$6.7 million, down from -$4.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $2.5 million in Q1 2024, with the low at -$12.8 million in Q2 2024.
• Historically, Cash from Investing Activities has averaged -$8.2 million across 5 years, with a median of -$8.7 million in 2023.
• Annual changes were most pronounced in 2024 — Cash from Investing Activities soared 126.62% — and 2025, when it slumped 494.74%.
• Medpace Holdings' Cash from Investing Activities stood at -$9.2 million in 2022, then rose by 13.26% to -$8.0 million in 2023, then advanced by 5.44% to -$7.6 million in 2024, then surged by 40.85% to -$4.5 million in 2025, then slumped by 50.86% to -$6.7 million in 2026.
• The last three Cash from Investing Activities figures came in at -$6.7 million (Q1 2026), -$4.5 million (Q4 2025), and -$10.7 million (Q3 2025), per Business Quant data.